156 related articles for article (PubMed ID: 1633109)
1. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells.
Bar-Ner M; Messing LT; Cultraro CM; Birrer MJ; Segal S
Cell Growth Differ; 1992 Mar; 3(3):183-90. PubMed ID: 1633109
[TBL] [Abstract][Full Text] [Related]
2. Regulation of murine Max (Myn) parallels the regulation of c-Myc in differentiating murine erythroleukemia cells.
Dunn BK; Cogliati T; Cultraro CM; Bar-Ner M; Segal S
Cell Growth Differ; 1994 Aug; 5(8):847-54. PubMed ID: 7986749
[TBL] [Abstract][Full Text] [Related]
3. Functional domains of c-Myc involved in the commitment and differentiation of murine erythroleukemia cells.
Ohmori Y; Tanabe J; Takada S; Lee WM; Obinata M
Oncogene; 1993 Feb; 8(2):379-86. PubMed ID: 8426744
[TBL] [Abstract][Full Text] [Related]
4. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
Chen J; Kremer CS; Bender TP
Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
[TBL] [Abstract][Full Text] [Related]
5. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of murine erythroleukemia cell differentiation by normal and partially deleted c-myc genes.
Bar-Ner M; Messing LT; Segal S
Immunobiology; 1992 Aug; 185(2-4):150-8. PubMed ID: 1452198
[TBL] [Abstract][Full Text] [Related]
7. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation.
Prochownik EV; Kukowska J
Nature; 1986 Aug 28-Sep 3; 322(6082):848-50. PubMed ID: 3528863
[TBL] [Abstract][Full Text] [Related]
8. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.
Rao G; Alland L; Guida P; Schreiber-Agus N; Chen K; Chin L; Rochelle JM; Seldin MF; Skoultchi AI; DePinho RA
Oncogene; 1996 Mar; 12(5):1165-72. PubMed ID: 8649810
[TBL] [Abstract][Full Text] [Related]
9. Transfected wild-type and mutant max regulate cell growth and differentiation of murine erythroleukemia cells.
Cogliati T; Dunn BK; Bar-Ner M; Cultraro CM; Segal S
Oncogene; 1993 May; 8(5):1263-8. PubMed ID: 8479748
[TBL] [Abstract][Full Text] [Related]
10. Functional analysis of the carboxy-terminal transforming region of v-Myc: binding to Max is necessary, but not sufficient, for cellular transformation.
Min S; Mascarenhas NT; Taparowsky EJ
Oncogene; 1993 Oct; 8(10):2691-701. PubMed ID: 8378081
[TBL] [Abstract][Full Text] [Related]
11. Effects of ornithine decarboxylase inhibition on c-myc expression during murine erythroleukemia cell proliferation and differentiation.
Watanabe T; Sherman M; Shafman T; Iwata T; Kufe D
J Cell Physiol; 1986 Jun; 127(3):480-4. PubMed ID: 3458709
[TBL] [Abstract][Full Text] [Related]
12. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions.
Koskinen PJ; Ayer DE; Eisenman RN
Cell Growth Differ; 1995 Jun; 6(6):623-9. PubMed ID: 7669717
[TBL] [Abstract][Full Text] [Related]
13. cAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation.
Suhasini M; Reddy CD; Reddy EP; DiDonato JA; Pilz RB
Oncogene; 1997 Oct; 15(15):1859-70. PubMed ID: 9362453
[TBL] [Abstract][Full Text] [Related]
14. Differential effects by Mad and Max on transformation by cellular and viral oncoproteins.
Cerni C; Bousset K; Seelos C; Burkhardt H; Henriksson M; Lüscher B
Oncogene; 1995 Aug; 11(3):587-96. PubMed ID: 7630643
[TBL] [Abstract][Full Text] [Related]
15. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
[TBL] [Abstract][Full Text] [Related]
16. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
18. Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells.
Waga K; Nakamura Y; Maki K; Arai H; Yamagata T; Sasaki K; Kurokawa M; Hirai H; Mitani K
Oncogene; 2003 Jan; 22(1):59-68. PubMed ID: 12527908
[TBL] [Abstract][Full Text] [Related]
19. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
Prins J; De Vries EG; Mulder NH
Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508
[TBL] [Abstract][Full Text] [Related]
20. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
Naderi S; Blomhoff HK
J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
